Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.
[alexander disease]
Alexander
disease
is
a
primary
genetic
disorder
of
astrocyte
caused
by
dominant
mutations
in
the
astrocyte-
specific
intermediate
filament
glial
fibrillary
acidic
protein
(
GFAP
)
.
While
most
of
the
disease-causing
mutations
described
to
date
have
been
found
in
the
conserved
α-helical
rod
domain
,
some
mutations
are
found
in
the
C-
terminal
non-α-helical
tail
domain
.
Here
,
we
compare
five
different
mutations
(
N
386
I
,
S
39
3
I
,
S
398
F
,
S
398
Y
and
D
417
M
14
X
)
located
in
the
C-
terminal
domain
of
GFAP
on
filament
assembly
properties
in
vitro
and
in
transiently
transfected
cultured
cells
.
All
the
mutations
disrupted
in
vitro
filament
assembly
.
The
mutations
also
affected
the
solubility
and
promoted
filament
aggregation
of
GFAP
in
transiently
transfected
MCF
7
,
SW
13
and
U
343
MG
cells
.
This
correlated
with
the
activation
of
the
p
38
stress-activated
protein
kinase
and
an
increased
association
with
the
small
heat
shock
protein
(
sHSP
)
chaperone
,
αB-crystallin
.
Of
the
mutants
studied
,
D
417
M
14
X
GFAP
caused
the
most
significant
effects
both
upon
filament
assembly
in
vitro
and
in
transiently
transfected
cells
.
This
mutant
also
caused
extensive
filament
aggregation
coinciding
with
the
sequestration
of
αB-crystallin
and
HSP
27
as
well
as
inhibition
of
the
proteosome
and
activation
of
p
38
kinase
.
Associated
with
these
changes
were
an
activation
of
caspase
3
and
a
significant
decrease
in
astrocyte
viability
.
We
conclude
that
some
mutations
in
the
C-
terminus
of
GFAP
correlate
with
caspase
3
cleavage
and
the
loss
of
cell
viability
,
suggesting
that
these
could
be
contributory
factors
in
the
development
of
Alexander
disease
.